Zachary Silbersher v. Allergan, Inc.

Good Law
United States Court of Appeals for the Ninth CircuitJanuary 29, 202523-15613California902 words

Opinion

Opinion

NOT FOR PUBLICATION FILED

UNITED STATES COURT OF APPEALS JAN 29 2025

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS

FOR THE NINTH CIRCUIT

UNITED STATES OF AMERICA, EX REL. No. 23-15613 ZACHARY SILBERSHER, Relator, D.C. No. 3:18-cv-03018-JCS Plaintiff-Appellant,

v. MEMORANDUM*

ALLERGAN, INC.; ALLERGAN USA,

INC.; ALLERGAN SALES, LLC; FOREST

LABORATORIES HOLDINGS, LTD.;

ADAMAS PHARMA LLC; ADAMAS

PHARMACEUTICALS, INC.,

Defendants-Appellees.

Appeal from the United States District Court for the Northern District of California Joseph C. Spero, Magistrate Judge, Presiding

Argued and Submitted November 21, 2024 San Jose, California

Before: FRIEDLAND and BUMATAY, Circuit Judges, and KENNELLY,** District Judge.

Appellant Zachary Silbersher appeals from the dismissal of his qui tam relator

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The Honorable Matthew F. Kennelly, United States District Judge for the Northern District of Illinois, sitting by designation. suit brought under the False Claims Act (“FCA”)…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.